Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

4.420

-0.190 (-4.12%)

At close: Aug 13, 2025, 4:00 PM

4.740

+0.320 (7.24%)

Pre-market: Aug 14, 2025, 9:05 AM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $12.63 million as of August 14, 2025. Its market cap has decreased by -83.54% in one year.

Market Cap

12.63M

Enterprise Value

-802.72K

1-Year Change

-83.54%

Ranking

#5096

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $12.63M, an increase of 68.37%. That is a compound annual growth rate of 2.67%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	6.80M	-44.72%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings